Osteogenesis of mesenchymal stem cells (MSCs) is highly dependent on oxygen supply. We have shown that perfluorotributylamine (PFTBA), a synthetic oxygen carrier, enhances MSC-based bone formation in vivo. Exploring this phenomenon's mechanism, we hypothesize that a transient increase in oxygen levels using PFTBA will affect MSC survival, proliferation, and differentiation, thus increasing bone formation. To test this hypothesis, MSCs overexpressing bone morphogenetic protein 2 were encapsulated in alginate beads that had been supplemented with an emulsion of PFTBA or phosphate-buffered saline. Oxygen measurements showed that supplementation of PFTBA significantly increased the available oxygen level during a 96-h period. PFTBA-containing beads displayed an elevation in cell viability, which was preserved throughout 2 weeks, and a significantly lower ratio of dead cells throughout the experiment. Furthermore, the cells from the control group expressed significantly more hypoxia-related genes such as VEGF, DDIT3, and PKG1. Additionally, PFTBA supplementation led to an increase in the osteogenic differentiation and to a decrease in chondrogenic differentiation of MSCs. In conclusion, PFTBA increases the oxygen availability in the vicinity of the MSCs, which suffer oxygen exhaustion shortly after encapsulation in alginate beads. Consequently, cell survival is increased, and hypoxia-related genes are downregulated. In addition, PFTBA promotes osteogenic differentiation over chondrogeneic differentiation, and thereby can accelerate MSC-based bone regeneration.
Get full access to this article
View all access options for this article.
References
1.
FrerichB., LindemannN., Kurtz-HoffmannJ., OertelK.In vitro model of a vascular stroma for the engineering of vascularized tissues. Int J Oral Maxillofac Surg, 30:414. 2001.
OkanoT., MatsudaT.Muscular tissue engineering: capillary-incorporated hybrid muscular tissues in vivo tissue culture. Cell Transplant, 7:435. 1998.
4.
MaldaJ., KleinT.J., UptonZ.The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng, 13:2153. 2007.
5.
NomiM., MiyakeH., SugitaY., FujisawaM., SokerS.Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. Curr Stem Cell Res Ther, 1:333. 2006.
6.
PattappaG., HeywoodH.K., de BruijnJ.D., LeeD.A.The metabolism of human mesenchymal stem cells during proliferation and differentiation. J Cell Physiol, 226:2562. 2011.
7.
SenguptaS., ParkS.H., PatelA., CarnJ., LeeK., KaplanD.L.Hypoxia and amino acid supplementation synergistically promote the osteogenesis of human mesenchymal stem cells on silk protein scaffolds. Tissue Eng Part A, 16:3623. 2010.
8.
GraysonW.L., ZhaoF., IzadpanahR., BunnellB., MaT.Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol, 207:331. 2006.
9.
KarlsenT.A., MirtaheriP., ShahdadfarA., FloisandY., BrinchmannJ.E.Effect of three-dimensional culture and incubator gas concentration on phenotype and differentiation capability of human mesenchymal stem cells. J Cell Biochem, 112:684. 2011.
10.
HolzwarthC., VaeglerM., GiesekeF., PfisterS.M., HandgretingerR., KerstG., MullerI.Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol, 11:11. 2010.
11.
MalladiP., XuY., ChiouM., GiacciaA.J., LongakerM.T.Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells. Am J Physiol Cell Physiol, 290:C1139. 2006.
12.
FehrerC., BrunauerR., LaschoberG., UnterluggauerH., ReitingerS., KlossF., GullyC., GassnerR., LepperdingerG.Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell, 6:745. 2007.
13.
D'IppolitoG., DiabiraS., HowardG.A., RoosB.A., SchillerP.C.Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone, 39:513. 2006.
14.
KrinnerA., ZscharnackM., BaderA., DrasdoD., GalleJ.Impact of oxygen environment on mesenchymal stem cell expansion and chondrogenic differentiation. Cell Prolif, 42:471. 2009.
15.
MaT., GraysonW.L., FrohlichM., Vunjak-NovakovicG.Hypoxia and stem cell-based engineering of mesenchymal tissues. Biotechnol Prog, 25:32. 2009.
16.
DasR., JahrH., van OschG.J., FarrellE.The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. Tissue Eng Part B Rev, 16:159. 2010.
17.
ZhuW., ChenJ., CongX., HuS., ChenX.Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells, 24:416. 2006.
18.
TamiyaH., IkedaT., JeongJ.H., SaitoT., YanoF., JungY.K., OhbaS., KawaguchiH., ChungU.I., ChoiJ.Y.Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. Gene, 416:53. 2008.
19.
RiddleR.C., KhatriR., SchipaniE., ClemensT.L.Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling. J Mol Med, 87:583. 2009.
ShomentoS.H., WanC., CaoX., FaugereM.C., BouxseinM.L., ClemensT.L., RiddleR.C.Hypoxia-inducible factors 1alpha and 2alpha exert both distinct and overlapping functions in long bone development. J Cell Biochem, 109:196. 2010.
22.
WanC., ShaoJ., GilbertS.R., RiddleR.C., LongF., JohnsonR.S., SchipaniE., ClemensT.L.Role of HIF-1alpha in skeletal development. Ann N Y Acad Sci, 1192:322. 2010.
JohnsonA.S., O'SullivanE., D'AoustL.N., OmerA., Bonner-WeirS., FisherR.J., WeirG.C., ColtonC.K.Quantitative assessment of islets of Langerhans encapsulated in alginate. Tissue Eng Part C Methods, 17:435. 2011.
25.
TanQ., El-BadryA.M., ContaldoC., SteinerR., HillingerS., WeltiM., HilbeM., SpahnD.R., JaussiR., HigueraG., van BlitterswijkC.A., LuoQ., WederW.The effect of perfluorocarbon-based artificial oxygen carriers on tissue-engineered trachea. Tissue Eng Part A, 15:2471. 2009.
BuckoM., GemeinerP., VikartovskaA., MislovicovaD., LacikI., TkacJ.Coencapsulation of oxygen carriers and glucose oxidase in polyelectrolyte complex capsules for the enhancement of D-gluconic acid and delta-gluconolactone production. Artif Cells Blood Substitutes Immobil Biotechnol, 38:90. 2010.
28.
FujitaH., ShimizuK., MoriokaY., NagamoriE.Enhancement of C2C12 differentiation by perfluorocarbon-mediated oxygen delivery. J Biosci Bioeng, 110:359. 2010.
29.
KhattakS.F., ChinK.S., BhatiaS.R., RobertsS.C.Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol Bioeng, 96:156. 2007.
30.
Kimelman-BleichN., PelledG., SheynD., KallaiI., ZilbermanY., MizrahiO., TalY., TawackoliW., GazitZ., GazitD.The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo. Biomaterials, 30:4639. 2009.
31.
HwangN.S., VargheseS., LeeH.J., ZhangZ., YeZ., BaeJ., ChengL., ElisseeffJ.In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A, 105:20641. 2008.
32.
FuT.S., UengS.W., TsaiT.T., ChenL.H., LinS.S., ChenW.J.Effect of hyperbaric oxygen on mesenchymal stem cells for lumbar fusion in vivo. BMC Musculoskelet Disord, 11:52. 2010.
33.
YuJ., DuK.T., FangQ., GuY., MihardjaS.S., SieversR.E., WuJ.C., LeeR.J.The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials, 31:7012. 2010.
AslanH., ZilbermanY., KandelL., LiebergallM., OskouianR.J., GazitD., GazitZ.Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells, 24:1728. 2006.
37.
EstesB.T., DiekmanB.O., GimbleJ.M., GuilakF.Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc, 5:1294. 2010.
38.
FinkT., LundP., PilgaardL., RasmussenJ.G., DurouxM., ZacharV.Instability of standard PCR reference genes in adipose-derived stem cells during propagation, differentiation and hypoxic exposure. BMC Mol Biol, 9:98. 2008.
39.
KallaiI., MizrahiO., TawackoliW., GazitZ., PelledG., GazitD.Microcomputed tomography-based structural analysis of various bone tissue regeneration models. Nat Protoc, 6:105. 2011.
40.
GohF., GrossJ.D., SimpsonN.E., SambanisA.Limited beneficial effects of perfluorocarbon emulsions on encapsulated cells in culture: experimental and modeling studies. J Biotechnol, 150:232. 2010.
41.
MayerH., BertramH., LindenmaierW., KorffT., WeberH., WeichH.Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem, 95:827. 2005.
42.
KumarS., WanC., RamaswamyG., ClemensT.L., PonnazhaganS.Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther, 18:1026. 2010.
43.
JungY., ShiozawaY., WangJ., WangJ., WangZ., PedersenE.A., LeeC.H., HallC.L., HoggP.J., KrebsbachP.H., KellerE.T., TaichmanR.S.Expression of PGK1 by prostate cancer cells induces bone formation. Mol Cancer Res, 7:1595. 2009.
44.
CohenJ., ZaleskiK.L., NourissatG., JulienT.P., RandolphM.A., YaremchukM.J.Survival of porcine mesenchymal stem cells over the alginate recovered cellular method. J Biomed Mater Res Part A, 96:93. 2011.
45.
GohF., SambanisA.In vivo noninvasive monitoring of dissolved oxygen concentration within an implanted tissue-engineered pancreatic construct. Tissue Eng Part C Methods, 17:887. 2011.
46.
MarkwayB.D., TanG.K., BrookeG., HudsonJ.E., Cooper-WhiteJ.J., DoranM.R.Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures. Cell Transplant, 19:29. 2010.
47.
PiekE., HeldinC.H., Ten DijkeP.Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J, 13:2105. 1999.
48.
LeaskA., AbrahamD.J.All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci, 119:4803. 2006.
49.
KroeningS., NeubauerE., WesselJ., WiesenerM., Goppelt-StruebeM.Hypoxia interferes with connective tissue growth factor (CTGF) gene expression in human proximal tubular cell lines. Nephrol Dial Transplant, 24:3319. 2009.
50.
KondoS., KubotaS., MukudaiY., MoritaniN., NishidaT., MatsushitaH., MatsumotoS., SugaharaT., TakigawaM.Hypoxic regulation of stability of connective tissue growth factor/CCN2 mRNA by 3'-untranslated region interacting with a cellular protein in human chondrosarcoma cells. Oncogene, 25:1099. 2006.
51.
KubotaS., TakigawaM.The role of CCN2 in cartilage and bone development. J Cell Commun Signal, 5:209. 2011.
52.
MaedaA., NishidaT., AoyamaE., KubotaS., LyonsK.M., KubokiT., TakigawaM.CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem, 145:207. 2009.
53.
Smerdel-RamoyaA., ZanottiS., StadmeyerL., DurantD., CanalisE.Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia. Endocrinology, 149:4374. 2008.
NishidaT., NakanishiT., AsanoM., ShimoT., TakigawaM.Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol, 184:197. 2000.
56.
SafadiF.F., XuJ., SmockS.L., KanaanR.A., SelimA.H., OdgrenP.R., MarksS.C.Jr., OwenT.A., PopoffS.N.Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol, 196:51. 2003.
TamamaK., KawasakiH., KerpedjievaS.S., GuanJ., GanjuR.K., SenC.K.Differential roles of hypoxia inducible factor subunits in multipotential stromal cells under hypoxic condition. J Cell Biochem, 112:804. 2011.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
